Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases
Paul W. Sperduto(Methodist Hospital), Minesh P. Mehta(Columbia University), Robert J. Weil(Cleveland Clinic), David Roberge(Centre Hospitalier de l’Université de Montréal), Norbert Kased(Apple (Israel)), Amit Bhatt(Apple (Israel)), Penny K. Sneed(University of California, San Francisco), Helen A. Shih(Massachusetts General Hospital), Jonathan Knisely(Apple (Israel)), Nancy U. Lin(Dana-Farber Cancer Institute), Veronica Chiang(Yale University), Samuel T. Chao(Cleveland Clinic), Paul D. Brown(Mayo Clinic), Zhiyuan Xu(Zhejiang Cancer Hospital), Ryan Shanley(Apple (Israel)), John H. Suh(Cleveland Clinic), John P. Kirkpatrick(Duke University), John B. Fiveash(University of Alabama at Birmingham), Laurie E. Gaspar(University of Colorado Cancer Center), Christina Maria Sperduto(Dartmouth College), Ashley W. Jensen(Apple (Israel)), Xianghua Luo(Apple (Israel))
Cited by 1,418
Related Papers
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
|New England Journal of Medicine|2014|2.8k
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial
|The Lancet|2004|2.4k
Insights into Molecular Classifications of Triple-Negative Breast Cancer: Improving Patient Selection for Treatment
|Cancer Discovery|2019|1.4k
Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non–Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study
|Journal of Clinical Oncology|2019|1.3k
Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402
|Journal of Clinical Oncology|2012|1.2k